65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in Singapore

[ad_1] A unique company creation vehicle initiated by Lightstone Ventures and Evotec SE, and established with partners ClavystBio, Leaps by Bayer, Polaris Partners, and the Polaris Innovation Fund First-of-its-kind partnership…

Novo Nordisk and Evotec collaborate to launch LAB eN², a translational drug discovery accelerator, to address innovation gap in cardiometabolic diseases

[ad_1] LAB eN² will involve institutions including Harvard University, Mass General Brigham, and Beth Israel Deaconess Medical Center Focus of the collaboration is to accelerate the translation of academic ideas…